NewLink Genetics Corporation is covered by the following analysts.
Stephen D. Willey
Lumos Pharma is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Lumos Pharma's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Lumos Pharma or its management. Lumos Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.